9 Meters Biopharma, Inc. financial data

Symbol
NMTRQ on OTC
Industry
Pharmaceutical Preparations
Location
4509 Creedmoor Road, Suite 600, Raleigh, NC
State of incorporation
DE
Fiscal year end
December 31
Former names
INNOVATE BIOPHARMACEUTICALS, INC. (to 5/5/2020), Monster Digital, Inc. (to 1/11/2018), Tandon Digital, Inc. (to 8/12/2015)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134 % -80.5%
Debt-to-equity 267 % +1450%
Return On Equity -585 % -520%
Return On Assets -159 % -98%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.3M shares -94.4%
Common Stock, Shares, Outstanding 14.3M shares -94.4%
Entity Public Float 67.2M USD -75.6%
Common Stock, Value, Issued 1.43K USD -94.4%
Weighted Average Number of Shares Outstanding, Basic 13.6M shares +5.27%
Weighted Average Number of Shares Outstanding, Diluted 13.6M shares +5.27%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 11M USD +5.28%
Operating Income (Loss) -43.4M USD -1.67%
Nonoperating Income (Expense) -2.84M USD -10627%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -46.3M USD -8.39%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -46.3M USD -8.39%
Earnings Per Share, Basic -3.52 USD/shares +9.28%
Earnings Per Share, Diluted -3.52 USD/shares +9.28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.94M USD -81.4%
Assets, Current 9.2M USD -76.5%
Property, Plant and Equipment, Net 9.08K USD -47.5%
Operating Lease, Right-of-Use Asset 97.7K USD -36.4%
Other Assets, Noncurrent 8.98K USD +60.9%
Assets 9.31M USD -76.3%
Accounts Payable, Current 4.23M USD +121%
Employee-related Liabilities, Current 1.57M USD +37%
Accrued Liabilities, Current 5.76M USD -7.97%
Liabilities, Current 15.6M USD +89.4%
Operating Lease, Liability, Noncurrent 34.8K USD -64.7%
Liabilities 15.6M USD +87.6%
Retained Earnings (Accumulated Deficit) -226M USD -25.7%
Stockholders' Equity Attributable to Parent -6.3M USD -120%
Liabilities and Equity 9.31M USD -76.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.75M USD -0.01%
Net Cash Provided by (Used in) Financing Activities -12.3M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 550M shares 0%
Common Stock, Shares, Issued 14.3M shares -94.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22M USD -126%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.62M USD -79.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 174K USD
Deferred Tax Assets, Valuation Allowance 42.6M USD +27.3%
Operating Lease, Liability 98.4K USD -36.5%
Depreciation 1.33K USD -18.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 108K USD -40%
Property, Plant and Equipment, Gross 88K USD +3.34%
Operating Lease, Liability, Current 63.6K USD +12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 54K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 54K USD -25%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.61K USD -61.8%
Deferred Tax Assets, Operating Loss Carryforwards 21.4M USD +14.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 100K USD 0%
Additional Paid in Capital 220M USD +4.3%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.99M USD +48.6%
Interest Expense 3.42M USD +99661%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%